US EditionA Doctor Sees New Hope for Alzheimer’s Disease Patients and Families. He Wants You to Know Why
- Recently at Yale New Haven Health, a neurologist and surgeon reported that combining a blood test with two medications is drastically improving outcomes for patients and their families.
- Approved about two years ago, the drugs include Lecanemab and Kisunla , and Dr. Ausim Azizi said they 'clear the rust' and slow progression.
- Prior to the blood test, diagnosis required spinal fluid tests or PET scans, Dr. Ausim Azizi said.
- Starting treatment, 350 people have started on these drugs, `Dr. Ausim Azizi said`; patients feel better and have `more control` of their lives.
- The Alzheimer’s Association projects that over seven million Americans live with Alzheimer’s, projected to rise to almost 13 million by 2050, highlighting long-term challenges.
4 Articles
4 Articles
A doctor sees new hope for Alzheimer’s disease patients and families. He wants you to know why
HARTFORD, Conn. -- The combination of a recently approved blood test for detection of Alzheimer’s disease combined with two medications that slow progression of the disease is drastically improving outcomes for patients and their families, according to a neurologist and…
Why some people experience vision problems first in Alzheimer’s
A new study from University College London (UCL) has found that differences in brain protein distribution and inflammation may help explain why some people with Alzheimer’s disease first experience vision problems rather than memory loss. The study focused on a rare form of the disease called posterior cortical atrophy (PCA), which affects how the brain […] The post Why some people experience vision problems first in Alzheimer’s appeared first o…
Accelerating innovation in early Alzheimer’s disease diagnosis
Following a period of relative dormancy, research and development in the Alzheimer’s disease space is booming. And mounting attention, both in the development of disease modifying therapies (DMTs) and tests for the diagnosis of the disease, remain as important as ever.The post Accelerating innovation in early Alzheimer’s disease diagnosis appeared first on Medical Device Network.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
